Skip to main content

Table 2 Tolerance to house dust mite SLIT during treatment

From: Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergens

Patients with at least one follow-up visit (n = 278)
Patients with at least one adverse event reported during a follow-up visit*  
 No 226 (82.2%)
 Yes 49 (17.8%)
If yes**  
 At least one local reaction reported 41 (89.1%)
 At least one systemic reaction reported 7 (15.2%)
 At least one other reaction reported# 1 (2.2%)
  1. *Data missing, n = 3; **data missing, n = 3; #mainly pruritus.